Skip to main content
SpringerLink
Log in

Dipeptidyl peptidase-4 inhibitor-induced bullous pemphigoid

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Sun L, et al. Analysis of the Clinical Characteristics of Dipeptidyl Peptidase-4 Inhibitor-Induced Bullous Pemphigoid. Annals of Pharmacotherapy : 9 Jun 2021. Available from: URL: http://doi.org/10.1177/10600280211022722

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dipeptidyl peptidase-4 inhibitor-induced bullous pemphigoid. Reactions Weekly 1861, 9 (2021). https://doi.org/10.1007/s40278-021-97809-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-97809-1

Search

Navigation